Posts by Hajera Amatullah, PhD
-
Novel Therapeutic Strategy Identified for Crohn's Disease
Hajera Amatullah, PhD, Kate L. Jeffrey, PhD, and colleagues determined that loss of speckled protein 140 (SP140), a chromatin reader, results in uncontrolled topoisomerase activity. They recommend investigating topoisomerase inhibitors for the treatment of Crohn's disease in patients with SP140 mutations.
Biography
Hajera Amatullah, PhD, is a research fellow in the Center for the Study of Inflammatory Bowel Disease in the Division of Gastroenterology at Massachusetts General Hospital.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.